Novo Nordisk Says FDA Review of Hemophilia Drug Is Hitting Delays1 report from 1 outlet in 1 language · first reported 2026-10-02 22:28 UTC · updated 2026-10-02 22:28 UTC · JSONHealthNovoUnited States Food and Drug AdministrationReportsNovo Nordisk Says FDA Review of Hemophilia Drug Is Hitting Delaysmorningstar.com · en · 2026-10-02 22:28 UTC